Improved Mayo Endoscopic Score has a higher value for evaluating clinical severity of ulcerative colitis.
10.12122/j.issn.1673-4254.2022.07.05
- Author:
Ze Jun SONG
1
;
Ming Jun ZHANG
1
;
Yu Tang REN
1
;
Bo JIANG
1
Author Information
1. Department of Gastroenterology, Beijing Tsinghua Changgung Hospital, Beijing 102218, China.
- Publication Type:Journal Article
- Keywords:
endoscopy;
score;
severity;
ulcerative colitis
- MeSH:
Colitis, Ulcerative/diagnosis*;
Colonoscopy;
Humans;
ROC Curve;
Retrospective Studies;
Severity of Illness Index
- From:
Journal of Southern Medical University
2022;42(7):997-1005
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To assess the value of Improved Mayo Endoscopic Score (IMES) for evaluation of the clinical severity of ulcerative colitis (UC).
METHODS:We retrospectively analyzed the clinical and endoscopic data of 167 patients diagnosed with UC in Beijing Tsinghua Changgung Hospital from January, 2015 to November, 2021. The severity of endoscopic lesions was determined by Mayo Endoscopic Score (MES, 0-3 points) and the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) score (0-8 points), and the scope of endoscopic lesions was evaluated based on the Montreal classification system. The IMES was established by combining the MES with the Montreal classification.
RESULTS:The IMSE showed stronger correlations with modified Truelove and Witts Disease Severity, Mayo score and partial Mayo score (r=0.712, 0.784, and 0.703, respectively) than MES (r=0.642, 0.754, and 0.604, respectively), Montreal classification (r=0.598, 0.628, and 0.603, respectively) and UCEIS (r= 0.670, 0.767, and 0.677, respectively). ROC curve analysis showed that IMES was superior to MES, Montreal and UCEIS in diagnosis of severe and moderate- to-severe UC. IMES also showed stronger correlations with the laboratory indicators including CRP (r=0.583), WBC (r=0.235), HB (r=-0.280), PLT (r=0.352), ALB (r=-0.396) and ESR (r=0.471) than MES and Montreal classification. An IMES score of 5 was of greater value than a MES score of 3, E3, and UCEIS≥6 for predicting the administration of systemic hormones, immunosuppressants, or surgery in the near future.
CONCLUSION:IMES can better reflect the clinical severity of UC and has good correlations with the laboratory indicators of the patients.
